谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Supplementary Figures 1 - 9 from Biomarker Analyses from a Placebo-Controlled Phase II Study Evaluating Erlotinib ± Onartuzumab in Advanced Non–Small Cell Lung Cancer: MET Expression Levels Are Predictive of Patient Benefit

Hartmut Koeppen, Wei Yu,Jiping Zha,Ajay Pandita,Elicia Penuel,Linda Rangell,Rajiv Raja,Sankar Mohan,Rajesh Patel,Rupal Desai,Ling Fu,An Do,Vaishali Parab,Xiaoling Xia,Tom Januario,Sharianne G. Louie,Ellen Filvaroff,David S. Shames,Ignacio Wistuba,Marina Lipkind, Jenny Huang,Mirella Lazarov,Vanitha Ramakrishnan,Lukas Amler,See-Chun Phan,Premal Patel,Amy Peterson,Robert L. Yauch

openalex（2023）

引用 0|浏览3
关键词
Biomarker Analysis,Non-Small Cell Lung Cancer,Tumor Staging
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要